These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2343243)

  • 21. [Agonists of the imidazoline receptors].
    Ol'binskaia LI; Bochenkov IuV
    Eksp Klin Farmakol; 1999; 62(2):68-72. PubMed ID: 10340136
    [No Abstract]   [Full Text] [Related]  

  • 22. Rilmenidine alters renal function when administered intracerebroventricularly or intrarenally.
    Penner SB; Smyth DD
    Ann N Y Acad Sci; 1995 Jul; 763():353-6. PubMed ID: 7677346
    [No Abstract]   [Full Text] [Related]  

  • 23. Imidazoline Receptors in a Comprehensive Approach to Hypertension. Proceedings of an international symposium. Berlin, Germany, September 10, 1994.
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S1-67. PubMed ID: 8642799
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current data on the pharmacology of rilmenidine].
    Montastruc JL; Macquin-Mavier I; Damase-Michel C; Dard B; Tran MA; Valet P
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():25-9. PubMed ID: 2517006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits.
    Head GA; Godwin SJ; Sannajust F
    J Hypertens Suppl; 1993 Dec; 11(5):S322-3. PubMed ID: 7908963
    [No Abstract]   [Full Text] [Related]  

  • 26. [Imidazoline receptor agonists in the practical treatment of hypertension].
    Ol'binskaia LI; Bochenkov IuV; Alekseeva IL
    Ter Arkh; 1998; 70(2):86-8. PubMed ID: 9551585
    [No Abstract]   [Full Text] [Related]  

  • 27. [Conformational study of drugs which affect I1-imidazoline receptors].
    Garaj V; Remko M
    Ceska Slov Farm; 2002 Jul; 51(4):196-9. PubMed ID: 12183908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical assessment of prolonged therapy of patients with hypertension and diabetes with imidazoline receptor agonist moxonidine].
    Trusov VV; Aksenov KV; Filimonov MA
    Kardiologiia; 2002; 42(2):50-3. PubMed ID: 12494208
    [No Abstract]   [Full Text] [Related]  

  • 29. Second International Symposium on Rilmenidine. Paris, March 11, 1988. Proceedings.
    Am J Med; 1989 Sep; 87(3C):1S-74S. PubMed ID: 2782322
    [No Abstract]   [Full Text] [Related]  

  • 30. Rilmenidine and the high risk hypertensive patient.
    Laragh JH
    Ann N Y Acad Sci; 1995 Jul; 763():634-41. PubMed ID: 7677383
    [No Abstract]   [Full Text] [Related]  

  • 31. I1 agents: a new approach to the treatment of hypertension.
    Dubar M; Pillion G
    Ann N Y Acad Sci; 1995 Jul; 763():642-58. PubMed ID: 7677384
    [No Abstract]   [Full Text] [Related]  

  • 32. [Imidazole receptors: site of action of a new generation of antihypertensive drugs. Current status and future prospects].
    Molderings GJ; Michel MC; Göthert M; Christen O; Schäfer SG
    Dtsch Med Wochenschr; 1992 Jan; 117(2):67-71. PubMed ID: 1346103
    [No Abstract]   [Full Text] [Related]  

  • 33. Different types of centrally acting antihypertensive drugs.
    van Zwieten PA
    Eur Heart J; 1992 Jun; 13 Suppl A():18-21. PubMed ID: 1327795
    [No Abstract]   [Full Text] [Related]  

  • 34. [For the arterial pressure, the brain: a creed! "The scientific observation is always a polemic observation" (G. Bachelard)].
    Bousquet P
    Rev Med Interne; 1991; 12(4):259-62. PubMed ID: 1759063
    [No Abstract]   [Full Text] [Related]  

  • 35. [New perspectives in the treatment of hypertension: the contribution of rilmenidine].
    Polónia J
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II21-6. PubMed ID: 10874853
    [No Abstract]   [Full Text] [Related]  

  • 36. The contribution of I1-selective agents in the management of syndrome X.
    de Luca N; Argengiano L; Izzo R; Guerrera L; Iovino GL; Trimarco B
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II33-5. PubMed ID: 10874855
    [No Abstract]   [Full Text] [Related]  

  • 37. [Albarel (rilmenidin)--a selective I1 imidazole receptor agonist. Pharmacologic properties and experience in clinical use].
    Khirmanov VN
    Ter Arkh; 2003; 75(2):85-8. PubMed ID: 12685403
    [No Abstract]   [Full Text] [Related]  

  • 38. Imidazoline receptors: a new regulatory concept in blood pressure control. Symposium of the American Society of Hypertension meeting. New York, May 15-18, 1991.
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):45S-105S. PubMed ID: 1350727
    [No Abstract]   [Full Text] [Related]  

  • 39. New targets for drug action: is high selectivity always beneficial?
    Fredholm B; Abbott A
    Trends Pharmacol Sci; 1990 May; 11(5):175-8. PubMed ID: 2111592
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of agonist action using the operational model.
    Leff P
    Trends Pharmacol Sci; 1988 Nov; 9(11):395-8. PubMed ID: 3078075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.